NCT01105520

Brief Summary

Patients included in the study are treated at the Klinik für Neurochirurgie USZ. The clinical course is documented at Paraplegikerzentrum Balgrist using validated diagnostic procedures (e.g. SCIM, ASIA, neurophysiology). Study aims: Prognostic value of clinical diagnosis and additional diagnostic procedures? Which parameters exhibit optimal prognostic power? Differences between tumor/AVM associated lesions and traumatic lesions? What can we learn for pathophysiology and treatment?

  • Trial with surgical intervention

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 16, 2010

Completed
5.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

April 16, 2010

Status Verified

April 1, 2010

First QC Date

April 15, 2010

Last Update Submit

April 15, 2010

Conditions

Keywords

Intraspinal processes (tumor or vascular malformation AVM)

Study Arms (1)

intralspinal processes

Patients with intralspinal processes

Procedure: Diagnostic

Interventions

DiagnosticPROCEDURE

SCIM Spinal Cord Independence Measure ASIA scale American Spinal Injury Association

intralspinal processes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients treated surgically for intraspinal processes

You may qualify if:

  • Benign intraspinal process (tumor or vascular malformation AVM)
  • Primary lesion caudal of the brainstem, affecting C1
  • Cognitive ability to give written informed consent

You may not qualify if:

  • Metastases, malign tumors
  • Traumatic lesions
  • Myelitis, polyneuropathy
  • Disc prolaps

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Zurich, Switzerland

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • 01 Studienregister MasterAdmins

    UniversitaetsSpital Zuerich

    STUDY DIRECTOR

Central Study Contacts

01 Studienregister MasterAdmins

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 15, 2010

First Posted

April 16, 2010

Study Start

January 1, 2010

Study Completion

December 1, 2015

Last Updated

April 16, 2010

Record last verified: 2010-04

Locations